Smith Group Asset Management’s Sage Therapeutics SAGE Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2018
Q3 | – | Sell |
-5,160
| Closed | -$808K | – | 447 |
|
|
2018
Q2 | $808K | Buy |
5,160
+700
| +16% | +$110K | 0.02% | 184 |
|
|
2018
Q1 | $718K | Sell |
4,460
-2,380
| -35% | -$383K | 0.02% | 183 |
|
|
2017
Q4 | $1.13M | Hold |
6,840
| – | – | 0.04% | 164 |
|
|
2017
Q3 | $426K | Hold |
6,840
| – | – | 0.01% | 227 |
|
|
2017
Q2 | $545K | Sell |
6,840
-100
| -1% | -$7.97K | 0.02% | 205 |
|
|
2017
Q1 | $493K | Sell |
6,940
-10
| -0.1% | -$710 | 0.01% | 185 |
|
|
2016
Q4 | $355K | Buy |
+6,950
| New | +$355K | 0.01% | 209 |
|